Archives: Contractor Email

** FAO LIVING WELL PHARMACIES ONLY **
Dear Contractor
Correspondence has been issued by SPPG on 28 April 2025 advising that the Living Well ‘Look after your mental health’ survey will now remain open until 6pm Wednesday 30th April 2025.

Contractors who have yet to complete this survey are asked to do so before the deadline.

To access the survey, please click here.

For any further information, please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
The first update of concessionary prices were granted yesterday for April 2025:
DrugPack SizeConcessionary Price
Alendronic acid 70mg tablets4£1.15
Chloramphenicol 1% eye ointment4£3.08
Clarithromycin 125mg/5ml oral suspension70£6.30
Duloxetine 30mg gastro-resistant capsules28£1.99
Duloxetine 60mg gastro-resistant capsules28£2.62
Fenofibrate micronised 160mg tablets28£3.60
Fusidic acid 1% modified-release eye drops5£35.00
(previously £21.00)
Isosorbide mononitrate 20mg tablets56£3.85
Isosorbide mononitrate 40mg tablets56£3.67
Lofepramine 70mg tablets56£25.60
Mometasone 0.1% cream30£3.63
Mometasone 0.1% ointment30£3.42
Mycophenolate mofetil 500mg tablets50£6.50
Naftidrofuryl 100mg capsules84£11.74
Nefopam 30mg tablets90£4.09
Ondansetron 4mg orodispersible tablets10£16.00
Oxybutynin 5mg tablets56£2.90
Prucalopride 2mg tablets28 £10.39
Rizatriptan 10mg orodispersible tablets sugar free3£8.18
Sitagliptin 100mg tablets28£1.67
Sitagliptin 25mg tablets28£1.14
Sitagliptin 50mg tablets28£1.18
Tacrolimus 0.1% ointment30£25.92
Tacrolimus 0.1% ointment60£47.28
Trimethoprim 50mg/5ml oral suspension sugar free100£5.99

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Pricing/Supply Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

MHRA UPDATE

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Pricing/Supply Reporter and Situation Reporter.

Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Contractor,

CPNI continues to press the Department of Health and SPPG for additional funding, including mitigation and support for the NIC and NMW/NLW cost increases applicable from April 2025.

Although CPNI has recently been advised by the Health Minister Mr Mike Nesbitt MLA that ‘community pharmacy funding pressures are being considered alongside the other priorities of the Department of Health’, the funding position as outlined in the letter that contractors received from SPPG dated 14th March 2025 here remains the current position.

With the impact of the first month of the NIC and NMW/NLW cost increases now being felt by the sector, CPNI will be holding two contractor meetings on 14th May (Belfast) and 15th May (Cookstown) to provide a further update to contractors following the May meeting of the CPNI Board. Further details regarding the contractor meetings will be shared in due course.

Should there be any funding updates in the meantime, CPNI will of course update you accordingly.

Please do not hesitate to contact the CPNI office or the CPNI Director representative for your area if you require any additional information at any stage.

Kind regards,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
Further to recent updates on FTY 2026/2027 contractors will note that NICPLD issued correspondence on 10 April 2025, outlining the process for employers to opt-in to the programme.

SUMMARY

  • The FTY 2026/2027 opt-in invitation issued by NICPLD is available here and key dates are available here.
  • The closing date for the opt-in window is 25 April 2025.
  • If a pharmacy opts-in they will receive a link asking them to complete a second step where they upload their training placement details and accept the Terms of Participation.
  • The closing date for the second step is 16 May 2025.

IMPORTANT CONTRACTOR CONSIDERATIONS

  • If a contractor decides to “opt-in” they should be fully aware that once they complete the second step to upload their placement details and accept the Terms, they are considered to have given their commitment to providing the relevant placement(s) to any trainee allocated to them by the NICPLD selection process, including circumstances where specific adjustments are required.
  • Contractors must be aware that some important aspects of the FTY 2026/2027 programme have not been finalised by NICPLD and are not likely to be available until 2026, such as the 2026/2027 Framework, Curriculum, Salary, Training Grant and programme SOPs.
  • It is likely that a CPNI contractor meeting will be scheduled to take place in May (details to follow), at which arrangements relating to the 2026/2027 FTY process will be discussed.
  • Any contractor who decides to opt-in prior to 25 April 2025, should not proceed to uploading their placement details or accepting the Terms unless they are fully satisfied with giving their commitment to participate in FTY 2026/2027.

ACTION

CPNI would urge any contractors who are considering participation in the FTY 2026/2027 programme to take the following steps prior to opting-in, uploading placement details, or accepting the Terms of Participation:

Should you have any questions, please do not hesitate to contact the CPNI team or email Ennis.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive